TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
EDAP

EDAP TMS SA

Healthcare · Medical Distribution

5.40$ -0.2% vs. previous close Closing price · As of: Aug 13, 2026

Ownership

Ownership Structure

Who owns EDAP TMS SA (EDAP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 74.9% of the shares are freely tradable; institutional investors hold 38.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 38.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 6.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 74.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 38Mio.

Largest Shareholders

Institutions

Institutions EDAP
Name Stake (%) Shares Change (%) Date
Soleus Capital Management, L.P. 19.48 7,309,254 +0.0 06/30/2026
Morgan Stanley - Brokerage Accounts 8.91 3,345,280 -0.2 03/31/2026
Rock Springs Capital Management LP 3.69 1,386,000 +0.6 06/30/2026
FLAX POND CAPITAL, LLC 2.09 783,446 -1.7 03/31/2026
Bruce & Co Inc 1.17 438,652 +0.0 03/31/2026
UBS Group AG 0.45 169,630 -19.8 03/31/2026
Parkman Healthcare Partners LLC 0.41 154,832 +0.0 06/30/2026
Essex Investment Management Company, LLC 0.39 146,005 +0.0 06/30/2026
OHE Financial Inc 0.36 134,960 +0.0 06/30/2026

Funds

Funds EDAP
Name Stake (%) Shares Change (%) Date
Bruce 1.11 414,794 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?